Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends that Matter for Health Exchange Coverage

Posted by Matt Breese on May 25, 2016

Find me on:

The following infographics highlight how Health Exchange health plans cover treatments in trending therapeutic areas. Typically, HIX formularies implement reimbursement controls that appear as a hybrid of commercial and medicare coverage.

HIV: For HIV treatments in the market, a payer pharmacy benefit analysis across channels shows that health exchange formularies are the most restrictive to these drugs. Click on the image to view more.

reality-check-hiv-may.png

Hepatitis C: An analysis of payer pharmacy benefit coverage for formularies associated with health exchanges reveals that roughly 50% of lives are restricted by a prior authorization or step therapy. Click on the image to view more.

reality-check-hepatitis-c-may.png

 

Immune Globulin: Coverage by channel shows that health exchange formularies designate IVIG products as "not covered" the most, as compared to commercial and medicare. Click on the image to view more.

reality-check-ivig-april16.png

PCSK9: A review of market access for the relatively new PCSK9 class of treatments shows the variation in coverage across channels. Health exchange formularies mirror commercial formularies closely, featuring only about 10% of lives with unrestricted access. Click on the image to view more.

reality-check-pcsk9-channel.png

Subscribe to the MMIT blog for more managed care and market access trends, with perspectives from payers and providers.

Subscribe for Weekly Trends that Matter

Topics: Industry Trends, Provider, Payer